Common Shares Outstanding: The number of class A shares currently held by investors.
Can-Fite Biopharma Ltd (CANF) had Common Shares Outstanding of 13.22M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$7.62M |
|
$0.01M |
|
$0.10M |
|
$7.72M |
|
$2.12M |
|
-- |
|
$1.42M |
|
$3.54M |
|
$4.18M |
|
$4.18M |
|
$4.18M |
|
|
Common Shares Outstanding |
13.22M |
| Cash Flow Statement Financials | |
$-4.75M |
|
$3.00M |
|
$3.37M |
|
$4.83M |
|
$6.45M |
|
$1.63M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|